Monday, 26 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
Hengrui Gains NMPA Approval for Phase III Study of SHR-8068 in PD-L1 Negative NSCLC
CompanyDrug

Hengrui Gains NMPA Approval for Phase III Study of SHR-8068 in PD-L1 Negative NSCLC

April 22, 2025
Kelun-Biotech Gains FDA Clearance for Phase I Trial of ADC SKB518
CompanyDrug

Kelun-Biotech Gains FDA Clearance for Phase I Trial of ADC SKB518

April 22, 2025
Grand Pharma's GPN02006 Shows Promising HCC Diagnostic Results in Trial
CompanyDrug

Grand Pharma’s GPN02006 Shows Promising HCC Diagnostic Results in Trial

April 22, 2025
Shanghai Operation Robot Secures RMB 100 Million Series C Funding for AI-Driven Surgical Robot Development
CompanyDeals

Shanghai Operation Robot Secures RMB 100 Million Series C Funding for AI-Driven Surgical Robot Development

April 22, 2025
Novo Nordisk Partners with JD Healthcare to Advance Obesity and Diabetes Management
CompanyDeals

Novo Nordisk Partners with JD Healthcare to Advance Obesity and Diabetes Management

April 22, 2025
Novo Nordisk's Wegovy Gets NMPA Label Update for Cardiovascular Risk Reduction
CompanyDrug

Novo Nordisk’s Wegovy Gets NMPA Label Update for Cardiovascular Risk Reduction

April 22, 2025
Broncus Medical Secures NMPA Approval for BroncAblate in Lung Cancer Treatment
CompanyMedical Device

Broncus Medical Secures NMPA Approval for BroncAblate in Lung Cancer Treatment

April 22, 2025
Rona Therapeutics Wins NMPA IND Approval for siRNA Hypertension Drug RN1871
CompanyDrug

Rona Therapeutics Wins NMPA IND Approval for siRNA Hypertension Drug RN1871

April 22, 2025
Shanghai Pharmaceuticals Partners with Organon to Market Women's Health Products in China
CompanyDeals

Shanghai Pharmaceuticals Partners with Organon to Market Women’s Health Products in China

April 22, 2025
HutchMed Completes Patient Enrollment for Orpathys in Gastric Cancer Trial
CompanyDrug

HutchMed Completes Patient Enrollment for Orpathys in Gastric Cancer Trial

April 22, 2025
Akeso's Ebdarokimab Receives NMPA Approval for Moderate to Severe Plaque Psoriasis
CompanyDrug

Akeso’s Ebdarokimab Receives NMPA Approval for Moderate to Severe Plaque Psoriasis

April 21, 2025
Shanghai Healthcare Administration Pushes for 11th Round of VBP
Policy / Regulatory

Shanghai Healthcare Administration Pushes for 11th Round of VBP

April 21, 2025
1 2 … 9 10 11 12 13 … 29 30
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up